KTTA Pasithea Soliqdan keyingi foyda

Pasithea Therapeutics Corp. (KTTA) kompaniyasining rasmiy ramzlari

Markaziy nerv tizimi (CNS) klinik sinovlari ma'lumotlarini qayta ishlash uchun dasturiy robotlarning joriy etilishi Pasithea Therapeutics (KTTA) rivojlanish vektorini belgilaydi. Kompaniyaning joriy foyda darajasi moliyaviy barqarorlikni namoyish etmoqda, bunda ko'rsatkich -0.02 miqdorida qat'iy belgilangan. Kapitalizatsiya ketamin terapiyasi klinikalarining tarmog'iga tayanadi, kichik molekulyar patentlar va grantlar esa erkin pul oqimining barqaror kirishini ta'minlaydi.

Pasithea Therapeutics (KTTA) Kompaniyaning sof foydasi: 04.07.2022 - 31.10.2026 davri uchun

pasitheaclinics.com (KTTA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Pasithea Therapeutics Corp.|KTTA - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi Pasithea Therapeutics Corp.|KTTA - Korxona qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya hisobiga balans qiymati Pasithea Therapeutics|KTTA - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor kapitallashuvi pasitheaclinics.com|KTTA - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Pasithea Therapeutics|KTTA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Pasithea Therapeutics Corp.|KTTA - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Pasithea Therapeutics Corp.|KTTA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Pasithea Therapeutics|Tezkor likvidlik koeffitsiyenti pasitheaclinics.com
- foyda va bozor multiplikatorlari tafsilotlari:
KTTA - Sof daromad
Fundamental baholash:Pasithea (KTTA)
Pasithea Therapeutics seriyali mahsuloti

ESG standartlarining Pasithea Therapeutics (KTTA) neyrodegenerativ kasalliklar tadqiqotlariga integratsiyasi operatsion samaradorlikka bevosita ta'sir ko'rsatadi, bu esa kompaniyaning -0.02 miqdoridagi foyda darajasi bilan aks etgan. Ushbu ko'rsatkich barcha xarajatlardan keyingi sof pul oqimini o'lchaydi, bu esa investorlarga aktivga kirish vaqtini optimallashtirish uchun biznesning haqiqiy rentabelligini aksiyalar bozoridagi talab bilan solishtirish imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|regencellbioscience.com - Soliqdan keyingi foyda|Sof foyda AXSM|Sof foyda ACADIA Pharma (ACAD)|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Sof moliyaviy natija Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Sof foyda|Sof moliyaviy natija catalystpharma.com CPRX|DNLI (Denali Therapeutics Inc.) - Sof daromad|HRMY: Soliqlar to‘langandan keyingi foyda|BHVN (Biohaven Pharmaceutical) - Sof foyda|AMLX: Yakuniy foyda|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Sof foyda AVXL (Anavex Life Sciences Corp.)|Sof foyda CeriBell Inc CBLL|PRTA: Sof daromad|Yakuniy foyda ALEC (Alector, Inc.)|ANNX (Annexon, Inc.) - Sof daromad|OMER: Soliqlar to‘langandan keyingi foyda|NGNE (Neurogene) - Sof foyda|ACIU: Yakuniy foyda|Sof foyda VYGR|NMRA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Scilex Holding Company SCLX|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|CGTX - Sof foyda|Inhibikase (IKT) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda SAVA (Cassava Pharma)|ASRT (Assertio Holdings) - Sof foyda|Kompaniyaning sof daromadi Coya COYA|Sof daromad VTGN (Vistagen Therapeutics)|Sof foyda ovidrx.com (OVID)|Acumen Pharma - Sof daromad|Soliqlar to‘langandan keyingi foyda CRVO (CervoMed Corporation)|Alterity Therapeutics Ltd - Sof foyda|Sof moliyaviy natija Clene Inc. CLNN|PEPG: Sof foyda|Sof daromad jupiterneurosciences.com|Kompaniyaning sof foydasi Relmada|Annovis Bio Corporation (ANVS) - Sof moliyaviy natija|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|Sof foyda fireflyneuro.com (AIFF)|Klotho Neurosciences - Sof daromad|Soliqlar to‘langandan keyingi foyda NRSN (NeuroSense Therapeutics Ltd)|RVPH: Sof daromad|MetaVia Inc - Soliqlar to‘langandan keyingi foyda|NRXS: Sof foyda|Helius Medical Technologies (HSDT) - Sof foyda|Kompaniyaning sof foydasi Passage Bio Inc.|Kompaniya foydasi NEUP (Neuphoria)|Sof foyda NERV|ATHA - Kompaniyaning sof daromadi|Addex Therapeutics - Sof daromad|Sof foyda Alzamend Neuro Inc. ALZN|CYCN - Kompaniyaning sof foydasi|Yakuniy foyda PTIX (Protagenic Therapeutics)|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|Kompaniyaning sof foydasi Brainstorm Cell|caratherapeutics.com - Soliqdan keyingi foyda|Sof foyda CHRO|Sof foyda eliemtx.com (ELYM)|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Sof moliyaviy natija Longboard (LBPH)|Marinus Pharmaceuticals - Sof foyda|Sof moliyaviy natija nkgenbiotech.com NKGN|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|SAGE: Soliqlar to‘langandan keyingi foyda|SNPX (Neurotrope) - Sof foyda|TRVN: Yakuniy foyda|Sof foyda VIGL|WENA - Kompaniyaning sof daromadi|Sof foyda CERE (Cerevel Therapeutics, Inc.)